Invesco Biotechnology & Genome ETF
PBE
PBE
64 hedge funds and large institutions have $52.9M invested in Invesco Biotechnology & Genome ETF in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 21 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
64
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$676K | |
| 2 | +$674K | |
| 3 | +$557K | |
| 4 |
MML Investors Services
Springfield,
Massachusetts
|
+$541K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$357K |
Top Sellers
| 1 | -$6.18M | |
| 2 | -$1.38M | |
| 3 | -$1.01M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$479K |
| 5 |
LPL Financial
San Diego,
California
|
-$430K |